Safety and Tolerance of Increased Doses of HRS-5346 Tablets in Healthy Subjects

Summary

This is a randomized, double-blind, placebo-controlled phase I clinical study. The primary objective is to evaluate the safety, tolerability, PK, and PD of single- and multiple-dose HRS-5346 in healthy subjects, and to evaluate the food effects on PK of HRS-5346.

Timeline

Start

2024-06-13

Primary completion

2025-01-09

Completion

2025-01-09

Drugs

Indications